Stocks and Investing Stocks and Investing
Fri, May 12, 2023

Justin Kim Maintained (APLS) at Buy with Increased Target to $108 on, May 12th, 2023


Published on 2024-10-28 03:43:58 - WOPRAI, Justin Kim
  Print publication without navigation


Justin Kim of Oppenheimer, Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Buy with Increased Target from $96 to $108 on, May 12th, 2023.

Justin has made no other calls on APLS in the last 4 months.



There are 10 other peers that have a rating on APLS. Out of the 10 peers that are also analyzing APLS, 3 agree with Justin's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Derek Archila of "Wells Fargo" Maintained at Hold with Increased Target to $76 on, Friday, May 5th, 2023
  • Tiago Fauth of "Credit Suisse" Maintained at Hold with Increased Target to $81 on, Friday, May 5th, 2023
  • Laura Chico of "Wedbush" Maintained at Hold with Increased Target to $67 on, Monday, April 17th, 2023


These are the ratings of the 7 analyists that currently disagree with Justin


  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $106 on, Monday, May 8th, 2023
  • Douglas Tsao of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $100 on, Friday, May 5th, 2023
  • Joseph Stringer of "Needham" Maintained at Strong Buy with Increased Target to $110 on, Friday, May 5th, 2023
  • Steven Seedhouse of "Raymond James" Maintained at Strong Buy with Increased Target to $156 on, Friday, May 5th, 2023
  • Madhu Kumar of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $141 on, Friday, April 14th, 2023
  • Annabel Samimy of "Stifel" Maintained at Strong Buy with Increased Target to $75 on, Tuesday, February 21st, 2023
  • Colleen Kusy of "Baird" Maintained at Buy with Increased Target to $105 on, Tuesday, February 21st, 2023
Contributing Sources